New Delhi: coronavirus Good News. India is hopeful of getting the Corona vaccine by November. Russia will give 100 million doses of Corona vaccine to India. For this, an agreement has been signed between Russia’s Autonomous Wealth Fund and India’s Dr. Reddy’s Laboratories. On behalf of Dr. Reddy’s Laboratories and Russian Autonomous Money Fund Russian Direct Investment Fund (RDIF), a clinical trial of this vaccine will be started in India after getting permission from the government. In collaboration with RDIF, Dr. Reddy’s will also distribute the vaccine in India. According to the statement, RDIF will start supplying the vaccine to Dr. Reddy by the end of this year.
Russia made world’s first corono vaccine
On August 11, Russia announced the creation of the world’s first corona vaccine. Russia’s Gamaleya National Institute has developed this vaccine. Currently, the clinical trial of the third phase of this vaccine is going on over 40 thousand volunteers. Kirill Dmitriev, Chief Executive Officer (CEO) of RDIF said, “He is very pleased to have signed an agreement with Dr. Reddy’s. India has been very badly affected by the Corona epidemic. We are sure that we will together India Provide a safe and scientifically valid option in the fight against Corona. “
Dr. Reddy’s Laboratories Managing Director GV Prasad said, “The first and second phase of this vaccine has yielded promising results. To ensure its safety and effectiveness for people in India and to meet the requirements of Indian regulators We will do a clinical trial for its third phase. “
There is no side effect of the vaccine
Significantly, on September 4, the results of the first and second phase clinical trials of this vaccine were published in Lancet magazine. No serious adverse effects of this vaccine have been shown so far. The final phase of the trial is still going on and the results are expected to be out in October-November this year. After the announcement of this agreement, Dr. Reddy’s shares registered a jump. Shares of the company closed at Rs 4,631.55, up 4.24 percent on the BSE.
